25 XP   0   0   10

Adhera Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Adhera Therapeutics Inc together

PenkeI guess you are interested in Adhera Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Adhera Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Adhera Therapeutics Inc

I send you an email if I find something interesting about Adhera Therapeutics Inc.

Quick analysis of Adhera Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Adhera Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.09
When do you have the money?
1 year
How often do you get paid?
35.9%

What is your share worth?

Current worth
$-3.64
Expected worth in 1 year
$-4.27
How sure are you?
43.6%

+ What do you gain per year?

Total Gains per Share
$-0.54
Return On Investment
-4,466.7%

For what price can you sell your share?

Current Price per Share
$0.01
Expected price per share
$0.01 - $0.02
How sure are you?
50%

1. Valuation of Adhera Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.01

Intrinsic Value Per Share

$-3.46 - $3.58

Total Value Per Share

$-7.11 - $-0.07

2. Growth of Adhera Therapeutics Inc (5 min.)




Is Adhera Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$26.3m-$23m-$591.8k-2.5%

How much money is Adhera Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$632.2k-$679.5k$47.2k7.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Adhera Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#989 / 1031

Most Revenue
#878 / 1031

Most Profit
#225 / 1031

Most Efficient
#330 / 1031

What can you expect buying and holding a share of Adhera Therapeutics Inc? (5 min.)

Welcome investor! Adhera Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Adhera Therapeutics Inc.

What can you expect buying and holding a share of Adhera Therapeutics Inc?

First you should know what it really means to hold a share of Adhera Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Adhera Therapeutics Inc is $0.012. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Adhera Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Adhera Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-3.64. Based on the TTM, the Book Value Change Per Share is $-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Adhera Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.49-4,080.5%-0.10-802.1%-0.11-932.1%-0.23-1,903.4%-0.18-1,527.3%
Usd Book Value Change Per Share-3.41-28,442.4%-0.16-1,300.7%-0.05-452.4%-0.22-1,871.2%-0.09-725.4%
Usd Dividend Per Share0.000.0%0.02184.1%0.07573.2%0.05423.3%0.07592.6%
Usd Total Gains Per Share-3.41-28,442.4%-0.13-1,116.7%0.01120.9%-0.17-1,448.0%-0.02-132.9%
Usd Price Per Share0.03-0.37-0.37-0.23-0.45-
Price to Earnings Ratio-0.02-1.07--0.57-0.03--0.28-
Price-to-Total Gains Ratio-0.01-5.17--1.33-0.70-1.07-
Price to Book Ratio-0.01--0.17--0.13--0.02-1.84-
Price-to-Total Gains Ratio-0.01-5.17--1.33-0.70-1.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.012
Number of shares83333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.05
Usd Book Value Change Per Share-0.16-0.22
Usd Total Gains Per Share-0.13-0.17
Gains per Quarter (83333 shares)-11,166.73-14,479.82
Gains per Year (83333 shares)-44,666.93-57,919.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17363-52030-4467716930-74849-57929
214726-104060-8934433860-149699-115848
322089-156089-13401150790-224548-173767
429451-208119-17867867720-299397-231686
536814-260149-22334584650-374246-289605
644177-312179-268012101580-449096-347524
751540-364209-312679118510-523945-405443
858903-416238-357346135440-598794-463362
966266-468268-402013152370-673644-521281
1073629-520298-446680169300-748493-579200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%9.030.00.023.1%18.090.05.015.9%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%15.024.00.038.5%40.069.04.035.4%
Dividend per Share2.00.02.050.0%7.00.05.058.3%11.00.09.055.0%14.00.025.035.9%14.00.099.012.4%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%5.015.00.025.0%17.022.00.043.6%42.067.04.037.2%

Fundamentals of Adhera Therapeutics Inc

About Adhera Therapeutics Inc

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Fundamental data was last updated by Penke on 2024-03-21 12:14:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Adhera Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Adhera Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Adhera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5,918.4%+5,918.4%
5Y-5,918.4%10Y-3,135.8%-2,782.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y-5,918.4%-452.4%-5,466.0%
10Y-3,135.8%-589.0%-2,546.8%
1.1.2. Return on Assets

Shows how efficient Adhera Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • -8,022.5% Return on Assets means that Adhera Therapeutics Inc generated $-80.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Adhera Therapeutics Inc:

  • The MRQ is -8,022.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1,622.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8,022.5%TTM-1,622.7%-6,399.8%
TTM-1,622.7%YOY-495.5%-1,127.1%
TTM-1,622.7%5Y-5,628.9%+4,006.2%
5Y-5,628.9%10Y-2,896.4%-2,732.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,022.5%-12.5%-8,010.0%
TTM-1,622.7%-12.2%-1,610.5%
YOY-495.5%-11.2%-484.3%
5Y-5,628.9%-13.3%-5,615.6%
10Y-2,896.4%-14.6%-2,881.8%
1.1.3. Return on Equity

Shows how efficient Adhera Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Adhera Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Adhera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-10.1%+10.1%
5Y-10.1%10Y-42.5%+32.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.0%+16.0%
TTM--15.8%+15.8%
YOY--13.9%+13.9%
5Y-10.1%-18.2%+8.1%
10Y-42.5%-19.1%-23.4%

1.2. Operating Efficiency of Adhera Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Adhera Therapeutics Inc is operating .

  • Measures how much profit Adhera Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Adhera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-5,155.5%+5,155.5%
5Y-5,155.5%10Y-2,664.6%-2,490.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y-5,155.5%-459.9%-4,695.6%
10Y-2,664.6%-596.9%-2,067.7%
1.2.2. Operating Ratio

Measures how efficient Adhera Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Adhera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y52.498-52.498
5Y52.49810Y28.542+23.956
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y52.4985.554+46.944
10Y28.5427.396+21.146

1.3. Liquidity of Adhera Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Adhera Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Adhera Therapeutics Inc:

  • The MRQ is 0.002. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.003. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.003-0.002
TTM0.003YOY0.018-0.015
TTM0.0035Y0.261-0.258
5Y0.26110Y0.514-0.252
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0023.987-3.985
TTM0.0034.440-4.437
YOY0.0185.569-5.551
5Y0.2616.158-5.897
10Y0.5146.492-5.978
1.3.2. Quick Ratio

Measures if Adhera Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Adhera Therapeutics Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.002-0.001
TTM0.002YOY0.012-0.010
TTM0.0025Y0.126-0.124
5Y0.12610Y0.412-0.286
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0013.653-3.652
TTM0.0024.158-4.156
YOY0.0125.515-5.503
5Y0.1266.012-5.886
10Y0.4126.206-5.794

1.4. Solvency of Adhera Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Adhera Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Adhera Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 598.07 means that Adhera Therapeutics Inc assets are financed with 59,807.4% credit (debt) and the remaining percentage (100% - 59,807.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Adhera Therapeutics Inc:

  • The MRQ is 598.074. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 345.462. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ598.074TTM345.462+252.612
TTM345.462YOY91.463+253.998
TTM345.4625Y1,608.712-1,263.250
5Y1,608.71210Y825.459+783.253
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ598.0740.336+597.738
TTM345.4620.330+345.132
YOY91.4630.267+91.196
5Y1,608.7120.367+1,608.345
10Y825.4590.378+825.081
1.4.2. Debt to Equity Ratio

Measures if Adhera Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Adhera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.076-0.076
5Y0.07610Y1.927-1.851
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY-0.334-0.334
5Y0.0760.431-0.355
10Y1.9270.476+1.451

2. Market Valuation of Adhera Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Adhera Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Adhera Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.02 means the investor is paying $-0.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Adhera Therapeutics Inc:

  • The EOD is -0.006. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.015. Based on the earnings, the company is expensive. -2
  • The TTM is 1.065. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.006MRQ-0.015+0.009
MRQ-0.015TTM1.065-1.080
TTM1.065YOY-0.568+1.633
TTM1.0655Y0.029+1.036
5Y0.02910Y-0.279+0.308
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.006-2.697+2.691
MRQ-0.015-2.422+2.407
TTM1.065-2.709+3.774
YOY-0.568-4.116+3.548
5Y0.029-6.257+6.286
10Y-0.279-6.478+6.199
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Adhera Therapeutics Inc:

  • The EOD is -0.743. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.858. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.702. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.743MRQ-1.858+1.115
MRQ-1.858TTM-4.702+2.844
TTM-4.702YOY-1.494-3.208
TTM-4.7025Y-2.195-2.507
5Y-2.19510Y-2.674+0.479
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.743-3.344+2.601
MRQ-1.858-2.939+1.081
TTM-4.702-3.486-1.216
YOY-1.494-5.592+4.098
5Y-2.195-8.464+6.269
10Y-2.674-8.872+6.198
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Adhera Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.01 means the investor is paying $-0.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Adhera Therapeutics Inc:

  • The EOD is -0.003. Based on the equity, the company is expensive. -2
  • The MRQ is -0.008. Based on the equity, the company is expensive. -2
  • The TTM is -0.168. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.003MRQ-0.008+0.005
MRQ-0.008TTM-0.168+0.160
TTM-0.168YOY-0.131-0.038
TTM-0.1685Y-0.021-0.147
5Y-0.02110Y1.840-1.861
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0032.198-2.201
MRQ-0.0082.042-2.050
TTM-0.1682.121-2.289
YOY-0.1312.907-3.038
5Y-0.0213.682-3.703
10Y1.8404.114-2.274
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Adhera Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.413-0.156-95%-0.054-98%-0.225-93%-0.087-97%
Book Value Per Share---3.644-2.537-30%-2.300-37%-1.698-53%-0.855-77%
Current Ratio--0.0020.003-50%0.018-91%0.261-99%0.514-100%
Debt To Asset Ratio--598.074345.462+73%91.463+554%1608.712-63%825.459-28%
Debt To Equity Ratio----0%-0%0.076-100%1.927-100%
Dividend Per Share---0.022-100%0.069-100%0.051-100%0.071-100%
Eps---0.490-0.096-80%-0.112-77%-0.228-53%-0.183-63%
Free Cash Flow Per Share---0.004-0.018+342%-0.046+1046%-0.111+2659%-0.111+2639%
Free Cash Flow To Equity Per Share---0.004-0.003-11%0.001-650%-0.061+1625%-0.012+242%
Gross Profit Margin--1.0001.0000%1.0000%1.097-9%1.090-8%
Intrinsic Value_10Y_max--3.578--------
Intrinsic Value_10Y_min---3.464--------
Intrinsic Value_1Y_max---0.040--------
Intrinsic Value_1Y_min---0.429--------
Intrinsic Value_3Y_max--0.184--------
Intrinsic Value_3Y_min---1.225--------
Intrinsic Value_5Y_max--0.774--------
Intrinsic Value_5Y_min---1.947--------
Market Cap86650.800-150%216627.0003813201.700-94%2907638.473-93%1965790.727-89%3964512.476-95%
Net Profit Margin----0%-0%-59.1840%-31.3580%
Operating Margin----0%-0%-51.5550%-26.6460%
Operating Ratio----0%-0%52.498-100%28.542-100%
Pb Ratio-0.003+60%-0.008-0.168+1943%-0.131+1487%-0.021+154%1.840-100%
Pe Ratio-0.006+60%-0.0151.065-101%-0.568+3609%0.029-152%-0.279+1719%
Price Per Share0.012-150%0.0300.370-92%0.365-92%0.229-87%0.448-93%
Price To Free Cash Flow Ratio-0.743+60%-1.858-4.702+153%-1.494-20%-2.195+18%-2.674+44%
Price To Total Gains Ratio-0.004+60%-0.0095.167-100%-1.335+15084%0.702-101%1.075-101%
Quick Ratio--0.0010.002-40%0.012-90%0.126-99%0.412-100%
Return On Assets---80.225-16.227-80%-4.955-94%-56.289-30%-28.964-64%
Return On Equity----0%-0%-0.1010%-0.4250%
Total Gains Per Share---3.413-0.134-96%0.015-23634%-0.174-95%-0.016-100%
Usd Book Value---26315441.000-23595360.250-10%-23003500.000-13%-15009750.150-43%-7695244.231-71%
Usd Book Value Change Per Share---3.413-0.156-95%-0.054-98%-0.225-93%-0.087-97%
Usd Book Value Per Share---3.644-2.537-30%-2.300-37%-1.698-53%-0.855-77%
Usd Dividend Per Share---0.022-100%0.069-100%0.051-100%0.071-100%
Usd Eps---0.490-0.096-80%-0.112-77%-0.228-53%-0.183-63%
Usd Free Cash Flow---29155.000-202038.750+593%-409500.000+1305%-891415.650+2958%-863064.000+2860%
Usd Free Cash Flow Per Share---0.004-0.018+342%-0.046+1046%-0.111+2659%-0.111+2639%
Usd Free Cash Flow To Equity Per Share---0.004-0.003-11%0.001-650%-0.061+1625%-0.012+242%
Usd Market Cap86650.800-150%216627.0003813201.700-94%2907638.473-93%1965790.727-89%3964512.476-95%
Usd Price Per Share0.012-150%0.0300.370-92%0.365-92%0.229-87%0.448-93%
Usd Profit---3535815.000-632203.750-82%-679500.000-81%-1613958.850-54%-1688960.718-52%
Usd Revenue----0%-0%19194.050-100%72670.154-100%
Usd Total Gains Per Share---3.413-0.134-96%0.015-23634%-0.174-95%-0.016-100%
 EOD+2 -6MRQTTM+5 -24YOY+6 -235Y+10 -2310Y+10 -23

3.2. Fundamental Score

Let's check the fundamental score of Adhera Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.006
Price to Book Ratio (EOD)Between0-1-0.003
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.002
Debt to Asset Ratio (MRQ)Less than1598.074
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-80.225
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Adhera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.397
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.016
Ma 100Greater thanMa 2000.017
OpenGreater thanClose0.014
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets44
Total Liabilities26,360
Total Stockholder Equity-26,315
 As reported
Total Liabilities 26,360
Total Stockholder Equity+ -26,315
Total Assets = 44

Assets

Total Assets44
Total Current Assets44
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 32
Other Current Assets 12
Total Current Assets  (as reported)44
Total Current Assets  (calculated)44
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities26,360
Long-term Liabilities0
Total Stockholder Equity-26,315
Total Current Liabilities
Short-term Debt 10,829
Short Long Term Debt 10,829
Accounts payable 2,352
Other Current Liabilities 13,079
Total Current Liabilities  (as reported)26,360
Total Current Liabilities  (calculated)37,089
+/- 10,729
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock31
Retained Earnings -59,981
Other Stockholders Equity 33,634
Total Stockholder Equity (as reported)-26,315
Total Stockholder Equity (calculated)-26,315
+/-0
Other
Capital Stock31
Cash and Short Term Investments 32
Common Stock Shares Outstanding 4,304
Current Deferred Revenue100
Liabilities and Stockholders Equity 44
Net Debt 10,797
Net Invested Capital -15,486
Net Working Capital -26,315
Short Long Term Debt Total 10,829



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-30
> Total Assets 
0
1,100
5,800
5,700
6,000
5,900
5,800
5,900
9,400
6,000
5,600
5,800
9,400
8,700
30,300
29,800
28,600
27,400
27,000
29,000
28,800
27,500
25,600
23,900
22,100
20,200
16,344
14,580
13,218
11,661
13,624
12,028
11,418
15,440
22,409
24,483
28,530
23,050
30,910
33,347
37,049
31,138
25,764
32,004
30,246
80,775
66,891
61,903
78,415
72,953
78,310
81,215
77,663
73,832
103,154
91,656
78,419
61,616
43,468
34,376
21,261
13,137
15,735
9,976
7,229
8,597
6,613
7,229
29,443
29,124
32,204
28,135
11,750
7,453
6,894
6,858
7,168
7,742
12,357
7,453
9,958
9,216
8,047
7,554
8,123
7,595
7,178
7,146
6,880
6,186
6,117
6,632
6,245
6,184
6,184
14,468
8,299
5,141
5,141
2,756
4,136
420
420
315
54
1
1
42
151
196
196
976
256
79
104
82
44
4482104792569761961961514211543154204204,1362,7565,1415,1418,29914,4686,1846,1846,2456,6326,1176,1866,8807,1467,1787,5958,1237,5548,0479,2169,9587,45312,3577,7427,1686,8586,8947,45311,75028,13532,20429,12429,4437,2296,6138,5977,2299,97615,73513,13721,26134,37643,46861,61678,41991,656103,15473,83277,66381,21578,31072,95378,41561,90366,89180,77530,24632,00425,76431,13837,04933,34730,91023,05028,53024,48322,40915,44011,41812,02813,62411,66113,21814,58016,34420,20022,10023,90025,60027,50028,80029,00027,00027,40028,60029,80030,3008,7009,4005,8005,6006,0009,4005,9005,8005,9006,0005,7005,8001,1000
   > Total Current Assets 
0
900
5,800
5,700
5,900
5,800
5,800
5,800
9,100
5,800
5,400
5,500
9,100
8,400
29,700
29,000
27,800
26,600
26,200
28,100
27,700
26,500
24,400
22,300
19,500
16,500
12,437
10,739
9,334
7,895
9,998
8,598
8,168
12,320
19,235
20,105
14,810
10,405
17,979
27,770
32,253
25,834
20,136
26,907
24,810
75,205
58,849
54,692
70,028
64,376
68,930
68,819
62,854
57,558
86,149
71,789
58,767
44,679
27,642
21,741
12,424
4,958
9,891
4,857
2,657
4,339
2,705
2,657
2,960
3,002
6,434
2,666
2,576
732
194
158
468
1,042
5,657
732
3,258
2,516
1,302
809
1,378
850
433
446
180
316
401
402
63
125
125
8,646
7,454
4,677
4,677
2,154
3,578
420
420
315
54
1
1
42
151
196
196
976
256
79
104
82
44
4482104792569761961961514211543154204203,5782,1544,6774,6777,4548,646125125634024013161804464338501,3788091,3022,5163,2587325,6571,0424681581947322,5762,6666,4343,0022,9602,6572,7054,3392,6574,8579,8914,95812,42421,74127,64244,67958,76771,78986,14957,55862,85468,81968,93064,37670,02854,69258,84975,20524,81026,90720,13625,83432,25327,77017,97910,40514,81020,10519,23512,3208,1688,5989,9987,8959,33410,73912,43716,50019,50022,30024,40026,50027,70028,10026,20026,60027,80029,00029,7008,4009,1005,5005,4005,8009,1005,8005,8005,8005,9005,7005,8009000
       Cash And Cash Equivalents 
0
500
3,400
3,200
3,200
3,900
2,000
1,900
4,000
700
400
300
4,000
1,300
23,300
25,300
26,200
25,300
20,700
24,500
24,300
23,500
22,300
20,400
18,000
10,700
10,720
9,654
7,896
6,256
8,727
7,599
7,149
11,760
17,647
18,694
14,110
9,021
16,881
16,580
23,132
16,792
11,185
16,279
13,542
25,797
18,521
11,078
15,911
26,769
21,254
26,874
21,081
28,481
50,048
53,036
41,295
27,704
15,727
16,614
8,719
1,084
7,926
3,431
748
2,630
1,074
748
1,066
1,124
4,705
1,044
976
596
99
97
441
909
5,520
216
3,203
1,824
1,163
726
1,313
710
307
321
80
105
216
264
9
106
106
8,354
6,506
3,918
3,918
1,644
2,692
50
50
65
0
1
1
42
151
76
76
849
133
32
69
58
32
325869321338497676151421106550502,6921,6443,9183,9186,5068,3541061069264216105803213077101,3137261,1631,8243,2032165,52090944197995969761,0444,7051,1241,0667481,0742,6307483,4317,9261,0848,71916,61415,72727,70441,29553,03650,04828,48121,08126,87421,25426,76915,91111,07818,52125,79713,54216,27911,18516,79223,13216,58016,8819,02114,11018,69417,64711,7607,1497,5998,7276,2567,8969,65410,72010,70018,00020,40022,30023,50024,30024,50020,70025,30026,20025,30023,3001,3004,0003004007004,0001,9002,0003,9003,2003,2003,4005000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,000
0
0
0
0
0
0
0
-3,986
0
0
0
0
0
5,380
6,397
8,289
8,031
9,712
5,629
39,677
37,583
39,903
50,204
32,142
40,207
34,969
33,174
20,357
29,236
12,282
12,687
11,714
6,240
921
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000009216,24011,71412,68712,28229,23620,35733,17434,96940,20732,14250,20439,90337,58339,6775,6299,7128,0318,2896,3975,38000000-3,98600000004,0000000000000000000000000000
       Net Receivables 
0
500
2,300
500
2,700
1,900
600
700
1,100
800
700
1,000
1,100
1,000
800
1,100
900
900
2,000
3,100
2,900
2,300
1,400
1,200
1,000
1,100
905
689
1,034
1,275
817
758
374
313
1,280
1,042
419
856
530
5,251
2,213
104
134
30
5,092
0
825
888
582
189
1,548
1,289
2,589
2,798
816
360
124
324
353
385
2,602
32
60
49
211
127
110
211
59
0
5
10
250
7
5
5
5
5
0
7
0
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135
48
48
94
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000009094484813500000000000000500070555572501050592111101272114960322,6023853533241243608162,7982,5891,2891,54818958288882505,092301341042,2135,2515308564191,0421,2803133747588171,2751,0346899051,1001,0001,2001,4002,3002,9003,1002,0009009001,1008001,0001,1001,0007008001,1007006001,9002,7005002,3005000
       Other Current Assets 
0
-100
100
2,000
0
0
3,200
3,200
4,000
4,300
4,300
4,200
4,000
6,100
5,400
2,100
100
0
3,200
200
100
300
400
300
200
400
550
159
200
190
295
96
522
162
254
301
159
190
275
442
318
469
711
779
488
9,674
1,765
2,510
2,297
2,543
3,144
2,943
3,252
3,719
3,838
3,911
3,572
3,853
4,323
371
1,005
541
1,905
1,377
1,698
1,582
1,521
1,698
1,835
1,878
1,724
1,612
1,600
129
90
56
22
128
137
509
55
192
139
83
65
140
126
125
100
211
185
138
55
19
19
212
448
158
469
184
323
370
370
250
54
0
0
0
0
0
120
127
123
47
35
24
12
1224354712312712000000542503703703231844691584482121919551381852111001251261406583139192555091371282256901291,6001,6121,7241,8781,8351,6981,5211,5821,6981,3771,9055411,0053714,3233,8533,5723,9113,8383,7193,2522,9433,1442,5432,2972,5101,7659,674488779711469318442275190159301254162522962951902001595504002003004003001002003,20001002,1005,4006,1004,0004,2004,3004,3004,0003,2003,200002,000100-1000
   > Long-term Assets 
0
200
-100
-100
100
100
100
100
300
200
200
300
300
300
600
800
800
800
800
900
1,100
1,000
1,200
1,600
2,600
3,700
3,907
3,841
3,884
3,766
3,626
3,430
3,250
3,120
3,174
4,378
13,720
12,645
12,931
5,577
4,796
5,304
5,628
5,097
5,436
5,570
8,042
7,211
8,387
8,577
9,380
12,396
14,809
16,274
17,005
19,867
19,652
16,937
15,826
12,635
8,837
8,179
5,844
5,119
4,572
4,258
3,908
4,572
26,483
26,122
25,770
25,469
9,174
6,721
6,700
6,700
6,700
6,700
6,700
6,721
6,700
6,700
6,745
6,745
6,745
6,745
6,745
6,700
6,700
5,870
5,716
6,230
6,182
6,059
6,059
5,822
844
0
464
602
558
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000055860246408445,8226,0596,0596,1826,2305,7165,8706,7006,7006,7456,7456,7456,7456,7456,7006,7006,7216,7006,7006,7006,7006,7006,7219,17425,46925,77026,12226,4834,5723,9084,2584,5725,1195,8448,1798,83712,63515,82616,93719,65219,86717,00516,27414,80912,3969,3808,5778,3877,2118,0425,5705,4365,0975,6285,3044,7965,57712,93112,64513,7204,3783,1743,1203,2503,4303,6263,7663,8843,8413,9073,7002,6001,6001,2001,0001,100900800800800800600300300300200200300100100100100-100-1002000
       Property Plant Equipment 
0
-100
-100
-100
100
100
100
100
200
200
200
200
200
300
600
700
800
700
700
900
1,000
1,000
1,200
1,600
2,500
3,700
3,856
3,792
3,674
3,565
3,419
3,236
3,071
2,955
2,926
3,503
3,962
3,261
3,758
3,675
3,907
4,474
4,797
4,698
4,949
5,160
6,113
6,751
7,956
8,173
8,949
11,971
14,401
15,444
16,151
16,112
15,711
15,004
13,888
12,301
8,502
7,844
5,841
5,116
4,569
4,684
3,899
4,569
3,695
3,334
2,991
2,690
2,429
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
29
72
72
245
219
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002192457272291000000000000000000000002,4292,6902,9913,3343,6954,5693,8994,6844,5695,1165,8417,8448,50212,30113,88815,00415,71116,11216,15115,44414,40111,9718,9498,1737,9566,7516,1135,1604,9494,6984,7974,4743,9073,6753,7583,2613,9623,5032,9262,9553,0713,2363,4193,5653,6743,7923,8563,7002,5001,6001,2001,0001,000900700700800700600300200200200200200100100100100-100-100-1000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
90
90
90
0
90
90
0
90
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,517
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,558
3,503
3,503
3,503
3,503
3,503
3,503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003,5033,5033,5033,5033,5033,5033,5580000000000000000000006,517000000000000000000000009090090900909090900000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
161
147
133
119
104
90
90
90
90
8,581
8,366
90
90
90
90
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,100
22,734
22,734
22,734
22,734
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
6,700
2,312
2,213
2,727
2,679
2,556
2,556
2,309
816
392
392
357
339
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003393573923928162,3092,5562,5562,6792,7272,2132,3126,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,70022,73422,73422,73422,73423,1000000000000000000000000090909090908,3668,581909090901041191331471610000000000000000000000000000
       Other Assets 
0
0
100
100
0
0
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,870
5,716
6,230
6,182
6,059
5,935
5,812
816
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000008165,8125,9356,0596,1826,2305,7165,8700000000000000000000000000000000000000000000000000000000000000000000000000000000000-1000010010000
> Total Liabilities 
0
1,600
1,600
1,500
1,700
1,500
1,400
1,500
1,800
1,700
1,500
1,500
1,800
800
1,400
1,800
1,900
2,500
1,700
2,100
2,100
2,000
2,300
2,000
2,600
3,600
1,893
2,389
2,388
2,096
2,197
1,866
1,792
1,946
5,412
7,794
14,842
14,405
25,054
13,914
13,582
13,232
14,848
15,508
20,722
22,627
14,470
16,245
15,240
17,386
21,867
23,356
26,149
30,496
28,777
28,255
28,676
22,396
19,344
15,926
15,938
16,396
16,688
16,613
14,115
18,120
19,809
14,115
12,274
9,842
15,888
12,260
11,712
13,081
11,117
11,060
12,310
14,806
19,654
13,081
20,145
13,587
11,698
10,049
8,523
7,332
5,692
6,071
5,477
2,968
2,699
4,159
4,615
5,736
5,736
2,337
2,185
2,214
2,214
5,267
9,520
10,307
10,307
12,148
14,080
14,774
14,774
16,382
20,390
25,302
25,302
20,971
22,063
22,265
23,197
22,869
26,360
26,36022,86923,19722,26522,06320,97125,30225,30220,39016,38214,77414,77414,08012,14810,30710,3079,5205,2672,2142,2142,1852,3375,7365,7364,6154,1592,6992,9685,4776,0715,6927,3328,52310,04911,69813,58720,14513,08119,65414,80612,31011,06011,11713,08111,71212,26015,8889,84212,27414,11519,80918,12014,11516,61316,68816,39615,93815,92619,34422,39628,67628,25528,77730,49626,14923,35621,86717,38615,24016,24514,47022,62720,72215,50814,84813,23213,58213,91425,05414,40514,8427,7945,4121,9461,7921,8662,1972,0962,3882,3891,8933,6002,6002,0002,3002,0002,1002,1001,7002,5001,9001,8001,4008001,8001,5001,5001,7001,8001,5001,4001,5001,7001,5001,6001,6000
   > Total Current Liabilities 
0
1,000
1,100
1,000
1,200
1,200
1,100
1,200
1,700
1,500
1,300
1,300
1,700
900
1,400
1,700
1,800
2,400
1,700
2,200
2,100
2,000
2,300
2,000
2,500
3,600
1,893
2,389
2,388
2,096
2,197
1,866
1,792
1,916
3,676
4,739
8,528
7,063
13,502
12,409
11,944
11,068
12,746
13,145
14,619
16,843
8,938
10,472
8,903
9,178
11,240
12,519
13,955
14,725
13,621
13,467
14,990
13,568
11,761
9,895
10,913
12,524
3,500
3,647
5,130
5,309
8,301
5,130
6,274
6,317
6,909
4,282
4,639
5,627
5,426
5,581
5,795
6,216
2,703
5,627
2,280
1,942
1,857
2,122
2,494
2,436
2,849
3,107
3,008
2,968
2,699
4,159
4,615
5,736
5,736
2,337
2,185
2,214
2,214
5,160
9,432
10,307
10,307
12,148
14,080
14,774
14,774
16,382
20,390
25,302
25,302
20,971
22,063
22,265
23,197
22,869
26,360
26,36022,86923,19722,26522,06320,97125,30225,30220,39016,38214,77414,77414,08012,14810,30710,3079,4325,1602,2142,2142,1852,3375,7365,7364,6154,1592,6992,9683,0083,1072,8492,4362,4942,1221,8571,9422,2805,6272,7036,2165,7955,5815,4265,6274,6394,2826,9096,3176,2745,1308,3015,3095,1303,6473,50012,52410,9139,89511,76113,56814,99013,46713,62114,72513,95512,51911,2409,1788,90310,4728,93816,84314,61913,14512,74611,06811,94412,40913,5027,0638,5284,7393,6761,9161,7921,8662,1972,0962,3882,3891,8933,6002,5002,0002,3002,0002,1002,2001,7002,4001,8001,7001,4009001,7001,3001,3001,5001,7001,2001,1001,2001,2001,0001,1001,0000
       Short-term Debt 
0
100
100
100
100
100
100
100
200
200
200
200
200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,673
22
2,860
2,864
3,031
7,483
7,294
7,168
9,368
9,605
9,741
9,884
1,685
1,949
2,193
2,431
2,479
2,678
3,560
4,226
4,490
4,809
4,992
4,968
4,884
5,109
4,854
4,112
0
0
317
0
2,005
317
0
0
2,269
0
759
1,450
1,519
1,515
1,615
1,623
5
1,450
0
0
0
0
0
0
0
300
307
686
917
1,472
1,499
444
1,906
0
0
0
89
1,338
5,228
5,330
5,330
5,795
6,254
6,318
6,318
6,494
6,539
0
6,663
7,346
7,992
8,585
9,626
10,591
10,829
10,82910,5919,6268,5857,9927,3466,66306,5396,4946,3186,3186,2545,7955,3305,3305,2281,338890001,9064441,4991,47291768630730000000001,45051,6231,6151,5151,5191,45075902,269003172,0050317004,1124,8545,1094,8844,9684,9924,8094,4904,2263,5602,6782,4792,4312,1931,9491,6859,8849,7419,6059,3687,1687,2947,4833,0312,8642,860221,6730000000000000000000002002002002002001001001001001001001000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
1,260
5,151
5,330
5,795
6,143
6,254
6,318
6,393
6,494
6,539
6,663
6,828
7,346
7,992
8,585
9,626
10,591
10,829
10,82910,5919,6268,5857,9927,3466,8286,6636,5396,4946,3936,3186,2546,1435,7955,3305,1511,2608900000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
500
600
500
500
500
500
400
500
700
500
500
500
300
700
800
900
1,500
800
1,300
1,200
600
1,300
800
1,600
2,100
759
1,058
1,038
648
538
730
694
559
918
1,265
1,665
1,269
955
1,922
1,774
2,390
1,850
1,869
1,818
1,652
2,735
3,249
2,885
2,944
2,097
3,488
3,433
4,437
3,908
2,543
3,379
4,216
2,795
2,319
1,311
2,039
1,239
1,141
2,114
2,139
2,679
2,114
3,922
3,315
2,611
2,197
2,536
3,670
3,780
4,054
4,168
4,581
2,686
1,606
1,238
687
581
502
759
763
1,031
1,332
1,500
663
619
938
1,028
5,291
1,033
1,135
851
294
270
955
876
1,403
1,403
2,123
2,253
8,456
2,257
2,280
2,287
2,309
2,309
2,339
2,312
2,397
2,410
2,318
2,352
2,3522,3182,4102,3972,3122,3392,3092,3092,2872,2802,2578,4562,2532,1231,4031,4038769552702948511,1351,0335,2911,0289386196631,5001,3321,0317637595025816871,2381,6062,6864,5814,1684,0543,7803,6702,5362,1972,6113,3153,9222,1142,6792,1392,1141,1411,2392,0391,3112,3192,7954,2163,3792,5433,9084,4373,4333,4882,0972,9442,8853,2492,7351,6521,8181,8691,8502,3901,7741,9229551,2691,6651,2659185596947305386481,0381,0587592,1001,6008001,3006001,2001,3008001,5009008007003005005005007005004005005005005006005000
       Other Current Liabilities 
0
400
400
400
600
600
500
700
1,000
600
600
600
1,000
600
700
900
900
900
900
900
900
1,400
1,000
1,200
900
1,500
1,134
1,331
1,350
1,448
1,659
1,136
1,098
1,357
17
2,199
1,497
1,847
1,433
3,004
2,876
1,510
1,528
1,671
1,849
2,533
1,796
2,948
2,159
2,214
1,727
2,237
2,888
3,534
2,177
3,443
4,126
3,709
3,545
2,067
4,348
5,973
2,261
2,506
2,699
3,044
3,550
2,699
2,318
2,655
1,519
1,571
1,255
507
127
12
12
12
12
2,456
1,042
1,255
1,276
1,620
1,735
1,673
1,818
1,475
1,201
142
245
451
363
2,796
2,796
1,003
1,134
1,064
1,944
2,867
3,328
2,565
3,574
4,230
5,573
4,087
6,199
103
3,475
13,174
7,697
11,286
11,759
11,283
11,161
4,254
13,079
13,0794,25411,16111,28311,75911,2867,69713,1743,4751036,1994,0875,5734,2303,5742,5653,3282,8671,9441,0641,1341,0032,7962,7963634512451421,2011,4751,8181,6731,7351,6201,2761,2551,0422,456121212121275071,2551,5711,5192,6552,3182,6993,5503,0442,6992,5062,2615,9734,3482,0673,5453,7094,1263,4432,1773,5342,8882,2371,7272,2142,1592,9481,7962,5331,8491,6711,5281,5102,8763,0041,4331,8471,4972,199171,3571,0981,1361,6591,4481,3501,3311,1341,5009001,2001,0001,4009009009009009009007006001,0006006006001,0007005006006004004004000
   > Long-term Liabilities 
0
600
500
500
500
300
300
300
100
200
200
200
100
-100
700
100
100
100
800
-100
1,200
600
1,300
800
100
2,100
759
1,058
1,038
648
538
730
694
30
1,736
3,055
6,314
7,342
11,552
1,505
1,638
2,164
2,102
2,363
6,103
5,784
5,532
5,773
6,337
8,208
10,627
10,837
12,194
15,771
15,156
14,788
13,686
8,828
7,583
6,031
5,025
3,872
13,188
12,966
8,985
12,811
11,508
8,985
6,000
3,525
8,979
7,978
7,073
7,454
5,691
5,479
6,515
8,590
16,951
7,454
17,865
11,645
9,841
7,927
6,029
4,896
2,843
2,964
2,469
1,349
1,536
2,411
2,526
0
2,940
1,335
1,051
0
270
107
88
0
6,733
7,918
8,507
0
8,575
8,774
8,826
0
8,972
9,685
10,304
10,982
3,638
0
0
003,63810,98210,3049,6858,97208,8268,7748,57508,5077,9186,73308810727001,0511,3352,94002,5262,4111,5361,3492,4692,9642,8434,8966,0297,9279,84111,64517,8657,45416,9518,5906,5155,4795,6917,4547,0737,9788,9793,5256,0008,98511,50812,8118,98512,96613,1883,8725,0256,0317,5838,82813,68614,78815,15615,77112,19410,83710,6278,2086,3375,7735,5325,7846,1032,3632,1022,1641,6381,50511,5527,3426,3143,0551,736306947305386481,0381,0587592,1001008001,3006001,200-100800100100100700-1001002002002001003003003005005005006000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000370000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,202
1,202
0
2,384
2,384
2,384
2,384
2,345
2,345
2,345
2,345
2,345
2,345
2,345
2,345
2,345
2,345
2,345
2,345
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000002,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3842,3842,3842,38401,2021,2020000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
-500
4,200
4,200
4,300
4,400
4,400
4,400
7,600
4,300
4,100
4,300
7,600
7,900
28,900
28,000
26,700
24,900
25,300
26,900
26,700
25,500
23,300
21,900
19,500
16,600
14,451
12,191
10,830
9,565
11,427
10,162
9,626
13,494
16,997
16,689
13,688
8,645
5,856
19,433
23,467
17,906
10,916
16,496
9,524
58,148
52,421
45,658
63,175
55,567
56,443
57,859
51,514
43,336
74,377
63,401
49,743
39,220
24,124
18,450
5,323
-3,259
-953
-6,637
-6,886
-9,523
-13,196
-6,886
17,169
19,282
16,316
15,875
38
-5,628
-4,223
-4,202
-5,142
-7,064
-7,297
-5,628
-10,187
-4,371
-3,651
-2,495
-400
263
1,486
1,075
1,403
3,219
3,419
2,474
1,631
448
448
12,130
6,113
2,927
2,927
-2,511
-5,384
-9,887
-9,887
-11,833
-14,026
-14,773
-14,773
-16,340
-20,239
-25,106
-25,106
-19,995
-21,807
-22,186
-23,093
-22,787
-26,315
-26,315-22,787-23,093-22,186-21,807-19,995-25,106-25,106-20,239-16,340-14,773-14,773-14,026-11,833-9,887-9,887-5,384-2,5112,9272,9276,11312,1304484481,6312,4743,4193,2191,4031,0751,486263-400-2,495-3,651-4,371-10,187-5,628-7,297-7,064-5,142-4,202-4,223-5,6283815,87516,31619,28217,169-6,886-13,196-9,523-6,886-6,637-953-3,2595,32318,45024,12439,22049,74363,40174,37743,33651,51457,85956,44355,56763,17545,65852,42158,1489,52416,49610,91617,90623,46719,4335,8568,64513,68816,68916,99713,4949,62610,16211,4279,56510,83012,19114,45116,60019,50021,90023,30025,50026,70026,90025,30024,90026,70028,00028,9007,9007,6004,3004,1004,3007,6004,4004,4004,4004,3004,2004,200-5000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38
38
41
41
47
48
49
57
60
61
61
61
61
62
71
71
72
80
80
107
108
109
124
124
130
131
132
185,849
0
229,840
0
234,065
0
0
0
250,826
254,269
255,595
256,131
262,984
263,412
256,131
307,939
313,717
314,336
318,282
320,232
324,112
324,141
324,169
324,205
324,247
155
324,112
155
153
154
159
159
166
176
179
179
539
583
59
60
63
63
65
65
65
65
65
65
65
65
65
65
67
67
71
87
102
102
379
18
19
19
23
31
3123191918379102102877167676565656565656565656563636059583539179179176166159159154153155324,112155324,247324,205324,169324,141324,112320,232318,282314,336313,717307,939256,131263,412262,984256,131255,595254,269250,826000234,0650229,8400185,8491321311301241241091081078080727171626161616160574948474141383800000000000000000000000000
   Retained Earnings Total Equity000000000-46,828-45,922-44,612-43,763-42,836-41,548-39,3270-31,922-28,7880-22,467-14,309-9,390-8,029-5,177-4,205-3,034-1,951-334,065-334,027-333,384-334,451-335,011-336,470-337,374-337,788-343,591-336,468-340,389-331,311-329,347-328,371-328,364-329,7400-302,407-298,0200000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-100
-100
-100
-100
-100
-100
-100
-100
0
0
0
0
0
-200
-200
-300
-300
-400
-400
-500
-600
-700
-800
-900
-1,000
-1,163
-1,346
-1,531
-1,694
-1,891
-2,088
-2,286
-2,483
-2,658
-2,992
-1,337
-1,219
-1,101
-984
-866
-749
-631
-1,416
-1,531
-1,359
-1,394
-1,449
-5,236
-5,009
-84
-73
-37
-20
-28
-39
21
20
28
2
-12,088
0
0
0
-7,773
0
0
0
-8,081
0
-8,081
-8,081
-9,253
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000-9,253-8,081-8,0810-8,081000-7,773000-12,0882282021-39-28-20-37-73-84-5,009-5,236-1,449-1,394-1,359-1,531-1,416-631-749-866-984-1,101-1,219-1,337-2,992-2,658-2,483-2,286-2,088-1,891-1,694-1,531-1,346-1,163-1,000-900-800-700-600-500-400-400-300-300-200-20000000-100-100-100-100-100-100-100-1000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332,937
332,985
333,249
333,264
333,569
333,816
334,452
334,548
334,694
334,923
335,289
4,631
5,870
6,836
6,851
8,414
8,533
26,374
28,516
0
29,105
29,346
0
29,375
29,650
29,674
29,672
29,772
30,347
30,417
0
0
0
0
0
0
0
0
0
00000000030,41730,34729,77229,67229,67429,65029,375029,34629,105028,51626,3748,5338,4146,8516,8365,8704,631335,289334,923334,694334,548334,452333,816333,569333,264333,249332,985332,937000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
6,000
10,700
10,700
10,600
10,600
10,600
10,600
13,900
10,600
10,600
10,600
13,800
14,000
36,000
36,000
36,100
36,300
36,600
37,900
38,000
38,100
38,200
38,300
38,000
37,900
38,062
38,237
41,054
41,221
45,589
46,583
48,072
55,155
61,631
63,121
61,872
62,506
62,524
63,031
73,189
73,428
73,963
87,811
88,509
142,853
143,247
144,882
174,985
176,068
179,860
181,824
183,250
185,849
228,438
229,840
232,572
234,065
235,479
244,162
259,195
0
0
0
263,904
0
0
0
8,081
0
8,081
8,081
9,253
0
0
0
0
0
0
332,937
333,249
333,264
333,569
333,816
334,452
334,548
334,694
334,923
335,289
4,631
5,870
6,620
6,748
0
8,414
26,374
28,516
0
28,710
29,346
29,418
0
29,375
29,650
29,672
0
29,772
30,417
30,647
0
27,809
33,184
33,545
33,546
33,551
33,608
33,634
33,63433,60833,55133,54633,54533,18427,809030,64730,41729,772029,67229,65029,375029,41829,34628,710028,51626,3748,41406,7486,6205,8704,631335,289334,923334,694334,548334,452333,816333,569333,264333,249332,9370000009,2538,0818,08108,081000263,904000259,195244,162235,479234,065232,572229,840228,438185,849183,250181,824179,860176,068174,985144,882143,247142,85388,50987,81173,96373,42873,18963,03162,52462,50661,87263,12161,63155,15548,07246,58345,58941,22141,05438,23738,06237,90038,00038,30038,20038,10038,00037,90036,60036,30036,10036,00036,00014,00013,80010,60010,60010,60013,90010,60010,60010,60010,60010,70010,7006,0000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-1,279
Operating Income-1,279-1,279
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,279
Selling And Marketing Expenses-
Operating Expense1,2791,279
 
Net Interest Income (+$)
Interest Income-
Interest Expense-3,195
Other Finance Cost-809
Net Interest Income-4,004
 
Pretax Income (+$)
Operating Income-1,279
Net Interest Income-4,004
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,486-2,077
EBIT - interestExpense = -3,195
-4,486
-1,291
Interest Expense3,195
Earnings Before Interest and Taxes (EBIT)--1,291
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-4,486
Tax Provision--
Net Income From Continuing Ops-4,486-4,486
Net Income-4,486
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net7984,004
 

Technical Analysis of Adhera Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Adhera Therapeutics Inc. The general trend of Adhera Therapeutics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Adhera Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Adhera Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.02 < 0.02 < 0.02.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Adhera Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Adhera Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Adhera Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Adhera Therapeutics Inc. The current macd is -0.0005457.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Adhera Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Adhera Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Adhera Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Adhera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAdhera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Adhera Therapeutics Inc. The current adx is 18.17.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Adhera Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Adhera Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Adhera Therapeutics Inc. The current sar is 0.01948435.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Adhera Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Adhera Therapeutics Inc. The current rsi is 47.40. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Adhera Therapeutics Inc Daily Relative Strength Index (RSI) ChartAdhera Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Adhera Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Adhera Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Adhera Therapeutics Inc Daily Stochastic Oscillator ChartAdhera Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Adhera Therapeutics Inc. The current cci is 11.69.

Adhera Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAdhera Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Adhera Therapeutics Inc. The current cmo is -5.13384719.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Adhera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAdhera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Adhera Therapeutics Inc. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Adhera Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Adhera Therapeutics Inc Daily Williams %R ChartAdhera Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Adhera Therapeutics Inc.

Adhera Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Adhera Therapeutics Inc. The current atr is 0.00272861.

Adhera Therapeutics Inc Daily Average True Range (ATR) ChartAdhera Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Adhera Therapeutics Inc. The current obv is 2,358,313.

Adhera Therapeutics Inc Daily On-Balance Volume (OBV) ChartAdhera Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Adhera Therapeutics Inc. The current mfi is 42.93.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Adhera Therapeutics Inc Daily Money Flow Index (MFI) ChartAdhera Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Adhera Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Adhera Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Adhera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.397
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.016
Ma 100Greater thanMa 2000.017
OpenGreater thanClose0.014
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Adhera Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Adhera Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Adhera Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Adhera Therapeutics Inc

I send you an email if I find something interesting about Adhera Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Adhera Therapeutics Inc.

Receive notifications about Adhera Therapeutics Inc in your mailbox!